Nexlizet

NDC 72426-818 · Esperion Therapeutics, Inc.

Generic nameBempedoic Acid and Ezetimibe

Dosage formTABLET, FILM COATED

RouteORAL

Active ingredient(s)BEMPEDOIC ACID, EZETIMIBE

Strength180; 10 mg/1; mg/1

Pharmacologic classAdenosine Triphosphate-Citrate Lyase Inhibitor [EPC], Adenosine Triphosphate-Citrate Lyase Inhibitors [MoA], Decreased Cholesterol Absorption [PE], Dietary Cholesterol Absorption Inhibitor [EPC]

Marketing categoryNDA

Packages

72426-818-03 — 30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (72426-818-03)

72426-818-99 — 7 TABLET, FILM COATED in 1 BLISTER PACK (72426-818-99)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

69238-1157 — Ezetimibe and Simvastatin, 69238-1158 — Ezetimibe and Simvastatin, 70771-1109 — ezetimibe, 71205-145 — Ezetimibe, 71205-277 — Ezetimibe, 71335-0684 — Ezetimibe, 71335-0933 — Ezetimibe, 71335-1127 — Ezetimibe, 71335-2123 — Ezetimibe, 71335-3092 — EZETIMIBE, 72426-118 — Bempedoic Acid, 76333-170 — Ezetimibe, 78206-174 — ezetimibe and simvastatin, 78206-175 — ezetimibe and simvastatin, 78206-176 — ezetimibe and simvastatin, 78206-177 — ezetimibe and simvastatin, 78206-178 — Ezetimibe, 82009-024 — ezetimibe, 82804-064 — Ezetimibe, 82804-211 — Ezetimibe, +56 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels